← Back to Search

Antimicrobial Solution

SQ53 Wipe for Catheter-related Bloodstream Infection

N/A

Waitlist Available

Led By Donald Kirby, MD

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will test the effectiveness of SQ53 in preventing catheter-related infections in patients receiving home parenteral nutrition.

Eligible Conditions

Catheter-related Bloodstream Infection (CRBSI)

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 Months

Secondary outcome measures

Catheter Exchange Rates

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SQ53 WipeExperimental Treatment1 Intervention

Participants will receive a supply of SQ53 wipes for daily use.

Group II: Standard WipeActive Control1 Intervention

Participants will receive a supply of ethanol-based wipes for daily use

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SQ53 Wipe

2021

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor

1,025 Previous Clinical Trials

1,365,817 Total Patients Enrolled

JVS Products, Ltd.UNKNOWN

Donald Kirby, MDPrincipal InvestigatorThe Cleveland Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this experiment being conducted with human participants?

"Affirmative, the information on clinicialtrials.gov displays that this clinical trial is actively enrolling participants. This research project was initially shared on December 10th 2021 and adjusted lastly on January 21st 2022. The investigation aims to recruit 60 individuals from a single medical location."

Answered by AI

Is there an ongoing enrollment period for this experiment?

"As per clinicaltrials.gov, this experiment is actively recruiting suitable participants. The trial was initially listed on December 10th 2021 and the details were updated most recently on January 21st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SQ53 Disinfectant Wipes for Prevention of CRBSI

Donald Kirby 2021. "SQ53 Disinfectant Wipes for Prevention of CRBSI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04822467.